Drug class profile · refreshed daily from federal data

Vitamin K

2 molecules in this class, — combined CY2024 Part D spend across — claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.

Last updated 14 Jul 2026

NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annualOrange Book: weeklyShortages: daily

Class summary at a glance.

Every drug in the Vitamin K class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 2tracked in Part D
CY24 Part D spend: —combined across class
Total Rx claims: —— unique beneficiaries
Generic mfrs (active): 15across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Phytonadione

Brand: Vitamin K1 · — Part D claims (CY24) · First FDA approval: 2003-04-18

15 generic mfrs

Low NADAC$9.38

→

Avg plan cost$9.38

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Vitamin K1 - Phytonadione

— Part D claims (CY24) · First FDA approval: 2021-05-10

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.